Biological Dynamics, Inc., a company developing and commercializing its proprietary ExoVerita™ platform for early disease detection and other applications, today announced Peter C. Wulff as Chief Financial Officer effective January 1, 2023.
Read MoreBiological Dynamics, Inc. (San Diego, CA), a molecular diagnostics company and a pioneer in the field of Alternating Current Electrokinetics (ACE)-based diagnostics, announced today the appointment of Wael Salameh, MD as VP of Clinical Development. In this role, Dr. Salameh will lead the efforts on analytical and clinical development of company's diagnostic portfolio.
Read MoreBiological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
